(Q58038022)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20802498%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

Adaptation of HIV-1 envelope gp120 to humoral immunity at a population level (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20802498%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20802498%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Matthijs R A Welkers

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20802498%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

7

Hanneke Schuitemaker

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20802498%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Zelda Euler

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20802498%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Brigitte D M Boeser-Nunnink

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20802498%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Marlous L Grijsen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20802498%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Jan M Prins

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20802498%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

language of work or name

English

0 references

publication date

29 August 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20802498%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20802498%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20802498%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20802498%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

995-997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20802498%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nm.2203

13 February 2020

exact match

0 references

cites work

Safety and pharmacokinetics of hyperimmune anti-human immunodeficiency virus (HIV) immunoglobulin administered to HIV-infected pregnant women and their newborns. Pediatric AIDS Clinical Trials Group Protocol 185 Pharmacokinetic Study Group

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNM.2203

Role of V1V2 and other human immunodeficiency virus type 1 envelope domains in resistance to autologous neutralization during clade C infection

21 January 2018

1 reference

12 December 2020

Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection

1 reference

12 December 2020

Antibody neutralization and escape by HIV-1

1 reference

12 December 2020

Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

1 reference

12 December 2020

Importance of the V1/V2 loop region of simian-human immunodeficiency virus envelope glycoprotein gp120 in determining the strain specificity of the neutralizing antibody response

1 reference

12 December 2020

Cross‐Reactive Neutralizing Humoral Immunity Does Not Protect from HIV Type 1 Disease Progression

1 reference

12 December 2020

Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection

1 reference

12 December 2020

Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody neutralization sensitivity

1 reference

12 December 2020

Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection

1 reference

12 December 2020

The V1/V2 domain of gp120 is a global regulator of the sensitivity of primary human immunodeficiency virus type 1 isolates to neutralization by antibodies commonly induced upon infection

1 reference

12 December 2020

Rapid evolution of the neutralizing antibody response to HIV type 1 infection

1 reference

12 December 2020

Adaptation of HIV-1 to human leukocyte antigen class I

1 reference

12 December 2020

Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies

1 reference

12 December 2020

Identifiers

DOI

10.1038/NM.2203

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20802498%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference